title: [Pharmacological and clinical profile of a novel SGLT2 inhibitor canagliflozin hydrate (CANAGLU®)].
authors.forename: Chiaki
authors.initials: C
authors.lastname: Kuriyama
authors.forename: Kiichiro
authors.initials: K
authors.lastname: Ueta
authors.forename: Kenji
authors.initials: K
authors.lastname: Arakawa
mesh_terms: D000818:Animals; D000068896:Canagliflozin / Q000737:chemistry / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000494:pharmacology*; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D015431:Weight Loss / Q000187:drug effects
chemical_list: D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D000068896:Canagliflozin; D005947:Glucose